GSK Investigational Site

Loures 2674-514

0 studies enrolling now · 1 studies all time

What they study most

Neoplasms, Breast

Studies at this site

• Efficacy and Safety Comparison of Niraparib to Placebo in Participants With Human Epidermal Growth Factor 2 Negative (HER2-) Breast Cancer Susceptibility Gene Mutation (BRCAmut) or Triple-Negative Breast Cancer (TNBC) With Molecular Disease — Running, not enrolling